Cargando…
Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical Candida albicans and non-albicans isolates
Candida species have a major role in nosocomial infections leading to high morbidity and mortality. Increased resistance to various antifungals, especially azoles is a significant problem. One of the main mechanisms for azole resistance is the up-regulation of efflux pump genes including CDR1 and MD...
Autores principales: | El-Ganiny, Amira M., Kamel, Hend A., Yossef, Nehal E., Mansour, Basem, El-Baz, Ahmed M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051972/ https://www.ncbi.nlm.nih.gov/pubmed/35498219 http://dx.doi.org/10.1016/j.jsps.2022.01.011 |
Ejemplares similares
-
Back to Nature: Combating Candida albicans Biofilm, Phospholipase and Hemolysin Using Plant Essential Oils
por: El-Baz, Ahmed M., et al.
Publicado: (2021) -
Prevalence and antifungal drug resistance of nosocomial Candida species isolated from two university hospitals in Egypt
por: M. El-Ganiny, Amira, et al.
Publicado: (2021) -
Relationship between Sap prevalence and biofilm formation among resistant clinical isolates of Candida albicans
por: Kadry, Ashraf A, et al.
Publicado: (2018) -
Serum repressing efflux pump CDR1 in Candida albicans
por: Yang, Yun-Liang, et al.
Publicado: (2006) -
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)